Mújica-Jiménez C, Castellanos-Martínez A, Muñoz-Clares R A
Departamento de Bioquímica, Facultad de Química, Universidad Nacional Autónoma de México, Mexico, DF 04510, Mexico.
Biochim Biophys Acta. 1998 Jul 28;1386(1):132-44. doi: 10.1016/s0167-4838(98)00093-4.
The antibiotic phosphomycin (1,2-epoxypropylphosphonic acid), an analog of phosphoenolpyruvate (PEP), behaved not as an inhibitor, but as an activator, of the enzyme phosphoenolpyruvate carboxylase (PEPC) from maize leaves. Multiple activation studies indicated that the analog binds to the Glc6P-allosteric site producing a more activated enzyme than Glc6P itself. Because of this, we used phosphomycin as a tool to further extend our understanding of the mechanisms of allosteric regulation of C4-PEPC. Initial velocity data from detailed kinetic studies, in which the concentrations of free and Mg-complexed PEP and phosphomycin were controlled, are consistent with: (1) the true activator is free phosphomycin, which competes with free PEP for the Glc6P-allosteric site; and (2) the Mg-phosphomycin complex caused inhibition by binding to the active site in competition with MgPEP. Therefore, although the Glc6P-allosteric site and the active site are able to bind the same ligands, they differ in the form of substrate and activator they bind. This important difference allows the full expression of the potential of activation and prevents inhibition by the activators, including the physiological ones, which are mostly uncomplexed at physiological free Mg2+ concentrations. At fixed low substrate concentrations, the saturation kinetics of the enzyme by phosphomycin showed positive cooperativity at pH 7.3 and 8.3, although at the latter pH, the kinetics of saturation by the substrate was hyperbolic. The cosolute glycerol greatly increased the affinity of the enzyme for phosphomycin and abolished the cooperativity in its binding, but did not eliminate the heterotropic effects of the activator. Therefore, the heterotropic and homotropic effects of the activator are not always coupled to the homotropic effects of the substrate, which argues against the two-state model previously proposed to explain the allosteric properties of maize-leaf PEPC.
抗生素磷霉素(1,2 - 环氧丙基膦酸)是磷酸烯醇式丙酮酸(PEP)的类似物,它对玉米叶片中的磷酸烯醇式丙酮酸羧化酶(PEPC)并非起抑制剂作用,而是起激活剂作用。多项激活研究表明,该类似物与葡萄糖 - 6 - 磷酸(Glc6P)变构位点结合,产生的酶比Glc6P本身更具活性。因此,我们将磷霉素用作一种工具,以进一步拓展我们对C4 - PEPC变构调节机制的理解。详细动力学研究的初始速度数据表明,在控制游离和镁络合的PEP以及磷霉素浓度的情况下,这些数据与以下情况一致:(1)真正的激活剂是游离磷霉素,它与游离PEP竞争Glc6P变构位点;(2)镁 - 磷霉素络合物通过与MgPEP竞争结合活性位点而导致抑制作用。因此,尽管Glc6P变构位点和活性位点能够结合相同的配体,但它们结合的底物和激活剂形式不同。这一重要差异使得激活潜力得以充分发挥,并防止激活剂(包括生理激活剂,在生理游离镁离子浓度下大多未络合)产生抑制作用。在固定的低底物浓度下,磷霉素对该酶的饱和动力学在pH 7.3和8.3时显示出正协同性,尽管在后者pH下,底物的饱和动力学呈双曲线形式。共溶质甘油极大地增加了酶对磷霉素的亲和力,并消除了其结合中的协同性,但并未消除激活剂的异促效应。因此,激活剂的异促和同促效应并不总是与底物的同促效应相关联,这与先前提出的用于解释玉米叶片PEPC变构特性的二态模型相悖。